Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma

Key points – PD-1 blockade with nivolumab provides durable disease control after allo-HCT. PD-1 blockade with nivolumab after allo-HCT is associated with 30% acute GVHD.